Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and captopril

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with captopril in 9 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Studies
(captopril)		Trials
(captopril)		Recent Studies (post-2010) (captopril)
9,15618755210,3201,514890

Protein Interaction Comparison

ProteinTaxonomy1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50)captopril (IC50)
Leukotriene A-4 hydrolaseHomo sapiens (human)3.6
Angiotensin-converting enzyme Homo sapiens (human)0.084
Angiotensin-converting enzymeOryctolagus cuniculus (rabbit)0.0173
Succinyl-diaminopimelate desuccinylaseHaemophilus influenzae Rd KW203.3
Angiotensin-converting enzymeRattus norvegicus (Norway rat)0.1004
Beta-lactamase Pseudomonas aeruginosa5
Angiotensin-converting enzyme 2 Homo sapiens (human)0.011
Beta-lactamase class B VIM-2 Pseudomonas aeruginosa3.5

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19903 (33.33)18.7374
1990's4 (44.44)18.2507
2000's2 (22.22)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
McDonald, DM; Nadel, JA; Piedimonte, G1
Bartha, K; Jenei, B; Lázár, G; Medgyesi, GA1
Krell, RD; McCarthy, M1
Calixto, JB; Trebien, HA1
Dunham, EW; Ma, YH1
Muirhead, EE1
Backer, CL; Crawford, SE; Gonzalez-Crussi, F; Hsueh, W; Huang, L; Liu, H; Mavroudis, C; Mu, Y; Takami, H1
Backer, CL; Crawford, SE; Huang, L; Huang, X; Mavroudis, C; Mu, Y; Pahl, E; Stellmach, V; Volpert, OV1
Medvedev, IN; Simonenko, VB; Tolmachev, VV1

Other Studies

9 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and captopril

ArticleYear
Neutral endopeptidase and kininase II mediate glucocorticoid inhibition of neurogenic inflammation in the rat trachea.
    The Journal of clinical investigation, 1991, Volume: 88, Issue:1

    Topics: Animals; Capillary Permeability; Captopril; Dexamethasone; Endopeptidases; Glycopeptides; Male; Peptidyl-Dipeptidase A; Platelet Activating Factor; Rats; Rats, Inbred Strains; Substance P; Trachea

1991
Hypotensive action of IgG preparations containing aggregates is suppressed by PAF-receptor antagonist BN 52021 and by gadolinium chloride (an agent blocking Kupffer cell function).
    Agents and actions, 1991, Volume: 32, Issue:3-4

    Topics: Animals; Captopril; Diterpenes; Female; Gadolinium; Ginkgolides; Hypotension; Immunoglobulin G; Kupffer Cells; Lactones; Macromolecular Substances; Platelet Activating Factor; Rats; Rats, Inbred Strains

1991
Pharmacologic analysis of platelet activating factor16- and 18-induced bronchoconstriction in the guinea pig.
    Annals of the New York Academy of Sciences, 1991, Volume: 629

    Topics: Animals; Atropine; Bronchoconstriction; Capsaicin; Captopril; Dose-Response Relationship, Drug; Guinea Pigs; Indomethacin; Leukocyte Count; Lung; Male; Methysergide; Platelet Activating Factor; Platelet Count; Propranolol; Pyrilamine; Respiratory Function Tests; Thiorphan

1991
Pharmacological evaluation of rat paw oedema induced by Bothrops jararaca venom.
    Agents and actions, 1989, Volume: 26, Issue:3-4

    Topics: Animals; Captopril; Crotalid Venoms; Dexamethasone; Edema; Hot Temperature; Indomethacin; Male; Masoprocol; Platelet Activating Factor; Prazosin; Quinacrine; Rats; Rats, Inbred Strains; Reference Values; Yohimbine

1989
Antagonism of the vasodilator effects of a platelet activating factor precursor in anesthetized spontaneously hypertensive rats.
    European journal of pharmacology, 1988, Jan-12, Volume: 145, Issue:2

    Topics: Animals; Captopril; Diacylglycerol Cholinephosphotransferase; Glyceryl Ethers; Hemodynamics; Male; Nitroprusside; Phospholipid Ethers; Platelet Activating Factor; Quinolines; Rats; Rats, Inbred SHR; Vasodilator Agents

1988
Vasodepressor lipid of the renomedullary interstitial cells of the renal papilla is a prohormone activated by the liver.
    Agents and actions. Supplements, 1987, Volume: 22

    Topics: Animals; Antihypertensive Agents; Blood Pressure; Captopril; Hypertension, Renovascular; Kidney Medulla; Liver; Phenobarbital; Platelet Activating Factor; Rats

1987
Captopril and platelet-activating factor (PAF) antagonist prevent cardiac allograft vasculopathy in rats: role of endogenous PAF and PAF-like compounds.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 1999, Volume: 18, Issue:5

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Azepines; Captopril; Coronary Disease; Disease Models, Animal; Drug Therapy, Combination; Heart Transplantation; Male; Platelet Activating Factor; Platelet Aggregation Inhibitors; Random Allocation; Rats; Rats, Inbred F344; Rats, Inbred Lew; Transplantation, Homologous; Treatment Outcome; Triazoles; Ventricular Remodeling

1999
Captopril suppresses post-transplantation angiogenic activity in rat allograft coronary vessels.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2004, Volume: 23, Issue:6

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cell Culture Techniques; Cell Movement; Cornea; Coronary Artery Disease; Disease Models, Animal; Endothelial Cells; Heart Transplantation; Male; Neovascularization, Physiologic; Platelet Activating Factor; Rats; Rats, Inbred F344; Rats, Inbred Lew; Vascular Endothelial Growth Factor A

2004
[Comparative evaluation of the influence of sulfhydryl and phosphate ACE inhibitors on thrombocyte aggregation in patients suffering from atrerial hypertension with metabolic syndrome].
    Klinicheskaia meditsina, 2007, Volume: 85, Issue:4

    Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Female; Fosinopril; Humans; Hypertension; Male; Metabolic Syndrome; Platelet Activating Factor

2007